HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk factors of esophagojejunal anastomotic leakage after total gastrectomy for gastric cancer.

AbstractBACKGROUND/AIMS:
The purpose of this study was to investigate the incidence of esophagojejunal anastomotic leakage (EJAL) after total gastrectomy.
METHODOLOGY:
Four hundred and four consecutive gastrectomy cases were reviewed to determine the incidence of esophagojejunal anastomotic leakage.
RESULTS:
EJAL developed in 33 patients (8.2%). The rate of leakage was found to be significantly related to the preoperative lymphocyte count and serum albumin level. Cases of para-aortic lymph node dissection (D4) had a significantly higher rate (16.1%) of EJAL than in conventional lymph node dissection (D2,3: 5.3%). The left upper abdominal evisceration group demonstrated a significantly higher EJAL rate (20.0%) than the cases without combined resection (4.8%).
CONCLUSION:
Aggressive surgery for advanced gastric cancer increases the risk of esophagojejunal anastomotic leakage. When aggressive surgery is necessary for curative purposes, meticulous preoperative, intraoperative and postoperative care are indispensable.
AuthorsH Isozaki, K Okajima, T Ichinona, H Hara, K Fujii, E Nomura
JournalHepato-gastroenterology (Hepatogastroenterology) 1997 Sep-Oct Vol. 44 Issue 17 Pg. 1509-12 ISSN: 0172-6390 [Print] Greece
PMID9356881 (Publication Type: Journal Article)
Topics
  • Anastomosis, Surgical (adverse effects)
  • Esophagus (surgery)
  • Extravasation of Diagnostic and Therapeutic Materials
  • Female
  • Gastrectomy
  • Humans
  • Incidence
  • Jejunum (surgery)
  • Male
  • Middle Aged
  • Postoperative Complications (diagnostic imaging, epidemiology)
  • Radiography
  • Risk Factors
  • Stomach Neoplasms (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: